Earnings Labs
CB

Cibus, Inc. (CBUS)

NASDAQ·Healthcare·Biotechnology

$1.41

-5.37%

Mkt Cap $188.24M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (3 analysts)

$11.50

Range $10.50$12.50

Implied Upside

+715.6%

Consensus $11.50 vs current $1.41